Peter Howarth

38.3k total citations · 11 hit papers
421 papers, 23.9k citations indexed

About

Peter Howarth is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Peter Howarth has authored 421 papers receiving a total of 23.9k indexed citations (citations by other indexed papers that have themselves been cited), including 312 papers in Physiology, 158 papers in Pulmonary and Respiratory Medicine and 132 papers in Immunology and Allergy. Recurrent topics in Peter Howarth's work include Asthma and respiratory diseases (307 papers), Allergic Rhinitis and Sensitization (122 papers) and Respiratory and Cough-Related Research (103 papers). Peter Howarth is often cited by papers focused on Asthma and respiratory diseases (307 papers), Allergic Rhinitis and Sensitization (122 papers) and Respiratory and Cough-Related Research (103 papers). Peter Howarth collaborates with scholars based in United Kingdom, United States and Italy. Peter Howarth's co-authors include Stephen T. Holgate, Ratko Djukanović, John Wilson, Donna E. Davies, W. R. Roche, Susan J. Wilson, Peter Bradding, Pascal Chanez, Héctor Ortega and Roland Buhl and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Peter Howarth

402 papers receiving 22.9k citations

Hit Papers

Mepolizumab for severe eosinophi... 1990 2026 2002 2014 2012 1990 1993 1994 1990 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
    2012 1.6k citations Peter Howarth et al. profile →
  2. Mucosal Inflammation in Asthma
    1990 1.1k citations Ratko Djukanović, John Wilson et al. profile →
  3. Induction of nitric oxide synthase in asthma
    1993 700 citations Peter Howarth, A E Redington et al. profile →
  4. Interleukin-4, -5, and -6 and Tumor Necrosis Factor-α in Normal and Asthmatic Airways: Evidence for the Human Mast Cell as a Source of these Cytokines
    1994 682 citations Ratko Djukanović, Peter Howarth et al. American Journal of Respiratory Cell and Molecular Biology profile →
  5. Myofibroblasts and Subepithelial Fibrosis in Bronchial Asthma
    1990 543 citations Peter Howarth, Ratko Djukanović et al. American Journal of Respiratory Cell and Molecular Biology profile →
  6. Effect of an Inhaled Corticosteroid on Airway Inflammation and Symptoms in Asthma
    1992 528 citations Ratko Djukanović, John Wilson et al. profile →
  7. Defective epithelial barrier function in asthma
    2011 479 citations Sarah M. Puddicombe, Hans Michael Haitchi et al. Journal of Allergy and Clinical Immunology profile →
  8. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation.
    1993 459 citations Susan J. Wilson, Stephen T. Holgate et al. The Journal of Immunology profile →
  9. Effect of Bronchoconstriction on Airway Remodeling in Asthma
    2011 420 citations Christopher Grainge, Laurie C.K. Lau et al. profile →
  10. Eosinophils in Health and Disease: A State-of-the-Art Review
    2021 164 citations Peter Howarth et al. profile →
  11. Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
    2024 47 citations Peter Howarth et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Howarth United Kingdom 79 16.8k 9.8k 7.2k 5.8k 2.5k 421 23.9k
Pascal Chanez France 76 18.7k 1.1× 14.6k 1.5× 4.5k 0.6× 5.1k 0.9× 2.0k 0.8× 447 25.6k
Andrew J. Wardlaw United Kingdom 82 19.5k 1.2× 12.5k 1.3× 5.7k 0.8× 8.3k 1.4× 1.8k 0.7× 267 27.2k
Charles G. Irvin United States 66 12.0k 0.7× 9.6k 1.0× 2.8k 0.4× 3.6k 0.6× 1.7k 0.7× 221 18.4k
Marsha Wills‐Karp United States 63 8.4k 0.5× 3.0k 0.3× 3.3k 0.5× 7.2k 1.2× 2.3k 0.9× 162 16.0k
Erwin W. Gelfand United States 86 9.2k 0.6× 4.5k 0.5× 3.7k 0.5× 11.8k 2.0× 6.8k 2.8× 610 27.3k
Nikolaos G. Papadopoulos Greece 64 5.5k 0.3× 4.8k 0.5× 4.4k 0.6× 2.8k 0.5× 7.1k 2.9× 639 24.3k
Donna E. Davies United Kingdom 65 6.5k 0.4× 5.0k 0.5× 1.6k 0.2× 3.9k 0.7× 2.5k 1.0× 295 14.6k
Robert Homer United States 72 5.7k 0.3× 7.9k 0.8× 1.4k 0.2× 7.0k 1.2× 5.6k 2.3× 203 21.2k
Ian M. Adcock United Kingdom 100 13.1k 0.8× 12.6k 1.3× 1.3k 0.2× 8.6k 1.5× 11.6k 4.7× 645 36.4k
Pieter S. Hiemstra Netherlands 78 5.4k 0.3× 6.9k 0.7× 985 0.1× 6.0k 1.0× 5.1k 2.1× 429 21.6k

Countries citing papers authored by Peter Howarth

Since Specialization
Citations

This map shows the geographic impact of Peter Howarth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Howarth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Howarth more than expected).

Fields of papers citing papers by Peter Howarth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Howarth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Howarth. The network helps show where Peter Howarth may publish in the future.

Co-authorship network of co-authors of Peter Howarth

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Howarth. A scholar is included among the top collaborators of Peter Howarth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Howarth. Peter Howarth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Azim, Adnan, Fransiskus Xaverius Ivan, Mahmoud I. Abdel‐Aziz, et al.. (2024). A severe asthma phenotype of excessive airway Haemophilus influenzae relative abundance associated with sputum neutrophilia. Clinical and Translational Medicine. 14(9). e70007–e70007. 7 indexed citations
3.
Casale, Thomas B., et al.. (2022). Oral corticosteroid-sparing effects of mepolizumab in severe eosinophilic asthma: evidence from randomized controlled trials and real-world studies. Therapeutic Advances in Respiratory Disease. 16. 2673686641–2673686641. 10 indexed citations
4.
Azim, Adnan, Colin Newell, Clair Barber, et al.. (2021). Clinical evaluation of type 2 disease status in a real‐world population of difficult to manage asthma using historic electronic healthcare records of blood eosinophil counts. Clinical & Experimental Allergy. 51(6). 811–820. 28 indexed citations
5.
Martínez-Núñez, Rocío T., Hitasha Rupani, Manuela Platé, et al.. (2018). Genome-Wide Posttranscriptional Dysregulation by MicroRNAs in Human Asthma as Revealed by Frac-seq. The Journal of Immunology. 201(1). 251–263. 22 indexed citations
6.
Smits, Hermelijn H., Pieter S. Hiemstra, Clarissa Prazeres da Costa, et al.. (2016). Microbes and asthma: Opportunities for intervention. Journal of Allergy and Clinical Immunology. 137(3). 690–697. 58 indexed citations
7.
Rupani, Hitasha, Rocío T. Martínez-Núñez, Patrick Dennison, et al.. (2016). Toll-like Receptor 7 Is Reduced in Severe Asthma and Linked to an Altered MicroRNA Profile. American Journal of Respiratory and Critical Care Medicine. 194(1). 26–37. 50 indexed citations
8.
Rupani, Hitasha, Tilman Sánchez-Elsner, & Peter Howarth. (2012). MicroRNAs and respiratory diseases. European Respiratory Journal. 41(3). 695–705. 73 indexed citations
9.
Maeda, Yutaka, Gang Chen, Yan Xu, et al.. (2011). Airway Epithelial Transcription Factor NK2 Homeobox 1 Inhibits Mucous Cell Metaplasia and Th2 Inflammation. American Journal of Respiratory and Critical Care Medicine. 184(4). 421–429. 51 indexed citations
10.
Nicholas, Ben, Paul Skipp, Sheila J. Barton, et al.. (2010). Identification of Lipocalin and Apolipoprotein A1 as Biomarkers of Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 181(10). 1049–1060. 59 indexed citations
11.
Haitchi, Hans Michael, Robert M. Powell, Tim Shaw, et al.. (2005). ADAM33 Expression in Asthmatic Airways and Human Embryonic Lungs. American Journal of Respiratory and Critical Care Medicine. 171(9). 958–965. 78 indexed citations
12.
Howarth, Peter, Niels Mygind, Philip E. Silkoff, & Alkis Togias. (2005). Preface to outcome measures in allergic rhinitis. Journal of Allergy and Clinical Immunology. 115(3). S387–S389. 7 indexed citations
13.
Polosa, Riccardo, Sarah M. Puddicombe, Mamidipudi Thirumala Krishna, et al.. (2002). Expression of c-erbB receptors and ligands in the bronchial epithelium of asthmatic subjects. Journal of Allergy and Clinical Immunology. 109(1). 75–81. 100 indexed citations
14.
Corne, Jonathan, et al.. (2001). The Relationship between Atopic Status and IL-10 Nasal Lavage Levels in the Acute and Persistent Inflammatory Response to Upper Respiratory Tract Infection. American Journal of Respiratory and Critical Care Medicine. 163(5). 1101–1107. 45 indexed citations
15.
Wallin, Annika, Thomas Sandström, Peter Howarth, et al.. (1999). The Effects of Regular Inhaled Formoterol, Budesonide, and Placebo on Mucosal Inflammation and Clinical Indices in Mild Asthma. American Journal of Respiratory and Critical Care Medicine. 159(1). 79–86. 109 indexed citations
16.
Howarth, Peter. (1998). Small Airways and Asthma: An Important Therapeutic Target?. American Journal of Respiratory and Critical Care Medicine. 157(5). S173–S173. 26 indexed citations
17.
Al-Ali, Musa & Peter Howarth. (1998). Nitric oxide and the respiratory system in health and disease. Respiratory Medicine. 92(5). 701–715. 30 indexed citations
18.
Redington, Anthony E., Jacqueline Madden, Ratko Djukanović, et al.. (1997). Transforming Growth Factor- β 1 in Asthma. American Journal of Respiratory and Critical Care Medicine. 156(2). 642–647. 362 indexed citations
19.
Howarth, Peter, A E Redington, D.R. Springall, et al.. (1995). Epithelially Derived Endothelin and Nitric Oxide in Asthma. International Archives of Allergy and Immunology. 107(1-3). 228–230. 26 indexed citations
20.
Howarth, Peter, et al.. (1990). Myofibroblasts and Subepithelial Fibrosis in Bronchial Asthma. American Journal of Respiratory Cell and Molecular Biology. 3(5). 507–511. 543 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pascal Chanez Breakdown of academic impact, for papers by Andrew J. Wardlaw Breakdown of academic impact, for papers by Charles G. Irvin Breakdown of academic impact, for papers by Marsha Wills‐Karp Breakdown of academic impact, for papers by Erwin W. Gelfand Breakdown of academic impact, for papers by Nikolaos G. Papadopoulos Breakdown of academic impact, for papers by Donna E. Davies Breakdown of academic impact, for papers by Robert Homer Breakdown of academic impact, for papers by Ian M. Adcock Breakdown of academic impact, for papers by Pieter S. Hiemstra
Rankless by CCL
2026